Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Uresta®

K-Number: K233548 · 2024-04-03

ApplicantResilia, Inc.
Decision Date2024-04-03
Product CodeHHW
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

Uresta® is the device name listed in this FDA 510(k) record. The listed applicant is Resilia, Inc.. It received FDA 510(k) clearance on 2024-04-03 under 510(k) number K233548. The device is classified under product code HHW. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Uresta®?

Uresta® is a medical device that received FDA 510(k) clearance on 2024-04-03. The listed applicant is Resilia, Inc.. The 510(k) number is K233548.

When did Uresta® receive FDA 510(k) clearance?

Uresta® received FDA 510(k) clearance on 2024-04-03, under 510(k) number K233548.

Who is the listed applicant for Uresta®?

The FDA 510(k) record lists Resilia, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Uresta®?

The FDA product code for Uresta® is HHW.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: HHW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.